Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 891–900 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 891
- Medicine slug
- loperamide
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 189
- Source count
- 41
- Agreement rate
- 1
- Recorded readings
10.8 hours
- Numeric value
- 10.8
- Unit
- hours
- Source records
- 41
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 41 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59e1c4cf-17cc-13c9-e063-6294a90af61c (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b0ac05b-90c1-476b-b001-5801dd21701d (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af0b886f-c065-26dc-e053-2995a90ac471 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca8de42f-8aea-4e35-ab3a-75ecea718f4f (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1be585e2-ef49-4210-8a2d-22a326e4cc1b (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42989f90-8ff5-44d1-a462-28c18ce02738 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:518bb0f0-88f2-1c95-e063-6294a90a722f (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a8c8d1d2-a8c7-462a-b620-729a9baa93c4 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:691c5dd6-b85d-482b-a8c1-8c4b48b48dc9 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 hours to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8d142533-4e87-4030-8fe9-4fc7473b0442 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:858c2b62-98e6-46d7-9253-9b3a00040a4e (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:97c37571-9116-40d6-ba07-f4a5a8d9b689 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2594967-e737-4a23-a710-290ca0e6a272 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f092b8a5-80b0-40ba-af45-2ac9edaa7704 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1adb7a28-9dc6-3f8b-e063-6394a90a9335 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3fdfc0e5-56a2-48a0-8ee6-390a194a29f3 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8bf47ac3-746f-47c3-82b2-32ac979ff963 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d69532c-c71a-4880-9f74-4b37d912cabd (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3e898141-8d40-49f1-e054-00144ff88e88 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Clinical studies have indicated that the apparent elimination half-life of loperamide hydrochloride in man is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f245e8f4-e06e-492e-8c46-af1fce1633fc (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ad71d4ab-d293-47a2-8f3f-2c9f42d76e40 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f031dfb-be55-5a44-e063-6394a90aeec5 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45a1e6b0-1e2b-958a-e063-6394a90a261d (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be99224e-dd49-4628-a5bf-ed8469ffd4a4 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d572ecf7-ddc3-46fb-80a6-80b7b1b90a1b (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:865cf4c7-f643-451b-b0d4-d30bda621f7d (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5322892-cb14-4a25-9b42-e62e491bc101 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df4e7076-fd25-aeb8-e053-2995a90a2aa0 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 hours to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3310a3c2-389a-4b27-a478-67c905789854 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e60cb25-6af9-4f17-b740-a5e7b5bb2a09 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 hours to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b0ac1a9-ffa6-9af6-e063-6294a90a2678 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74b9893a-18c3-4117-85c2-edab8e7b3b3b (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:86d94804-ad01-4106-8f23-033f3a6bab9e (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:330677ff-5426-40bd-af45-e3836cb77893 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 hours to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d92819f1-d02d-4959-a019-17d44df6ed2f (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:396f7e13-b357-52be-e063-6394a90a92fc (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72a7ae47-cdf3-4949-b9f8-f29b153f787f (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8992723-dd9a-bcf6-e053-6294a90aa65c (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 hours to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:580e6cd4-3f05-4996-9dc3-c50d757ae210 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03c907d5-87f8-47a6-9544-5a24f5272739 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e9dfe71-28a9-4b54-a0e1-7c0d82fec0d7 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Elimination The apparent elimination half-life of loperamide is 10.8 hours with a range of 9.1 to 14.4 hours.
Projected row 892
- Medicine slug
- loperamide
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 189
- Source count
- 40
- Agreement rate
- 1
- Recorded readings
95%
- Numeric value
- 95
- Unit
- %
- Source records
- 40
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 40 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59e1c4cf-17cc-13c9-e063-6294a90af61c (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b0ac05b-90c1-476b-b001-5801dd21701d (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af0b886f-c065-26dc-e053-2995a90ac471 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca8de42f-8aea-4e35-ab3a-75ecea718f4f (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1be585e2-ef49-4210-8a2d-22a326e4cc1b (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42989f90-8ff5-44d1-a462-28c18ce02738 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:518bb0f0-88f2-1c95-e063-6294a90a722f (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a8c8d1d2-a8c7-462a-b620-729a9baa93c4 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:691c5dd6-b85d-482b-a8c1-8c4b48b48dc9 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8d142533-4e87-4030-8fe9-4fc7473b0442 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:858c2b62-98e6-46d7-9253-9b3a00040a4e (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:97c37571-9116-40d6-ba07-f4a5a8d9b689 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2594967-e737-4a23-a710-290ca0e6a272 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f092b8a5-80b0-40ba-af45-2ac9edaa7704 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1adb7a28-9dc6-3f8b-e063-6394a90a9335 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3fdfc0e5-56a2-48a0-8ee6-390a194a29f3 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8bf47ac3-746f-47c3-82b2-32ac979ff963 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d69532c-c71a-4880-9f74-4b37d912cabd (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f245e8f4-e06e-492e-8c46-af1fce1633fc (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ad71d4ab-d293-47a2-8f3f-2c9f42d76e40 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f031dfb-be55-5a44-e063-6394a90aeec5 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45a1e6b0-1e2b-958a-e063-6394a90a261d (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be99224e-dd49-4628-a5bf-ed8469ffd4a4 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d572ecf7-ddc3-46fb-80a6-80b7b1b90a1b (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:865cf4c7-f643-451b-b0d4-d30bda621f7d (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5322892-cb14-4a25-9b42-e62e491bc101 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df4e7076-fd25-aeb8-e053-2995a90a2aa0 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3310a3c2-389a-4b27-a478-67c905789854 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e60cb25-6af9-4f17-b740-a5e7b5bb2a09 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3b0ac1a9-ffa6-9af6-e063-6294a90a2678 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:74b9893a-18c3-4117-85c2-edab8e7b3b3b (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:86d94804-ad01-4106-8f23-033f3a6bab9e (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:330677ff-5426-40bd-af45-e3836cb77893 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d92819f1-d02d-4959-a019-17d44df6ed2f (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:396f7e13-b357-52be-e063-6394a90a92fc (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72a7ae47-cdf3-4949-b9f8-f29b153f787f (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8992723-dd9a-bcf6-e053-6294a90aa65c (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:580e6cd4-3f05-4996-9dc3-c50d757ae210 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:03c907d5-87f8-47a6-9544-5a24f5272739 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e9dfe71-28a9-4b54-a0e1-7c0d82fec0d7 (opens source in a new tab)
Loperamide label
Version not recorded · Effective date not recorded
Distribution Based on literature information, the plasma protein binding of loperamide is about 95%.
Projected row 893
- Medicine slug
- lorazepam
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 106
- Source count
- 70
- Agreement rate
- 1
- Recorded readings
90%
- Numeric value
- 90
- Unit
- %
- Source records
- 70
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 70 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aac672f9-0ba7-4852-b8a7-caac9e4b1e77 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be85b116-9f09-403a-8e0d-e77e344d3a9a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b0619c5-b9e9-47e7-97b5-7e581e67cf5f (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam tablets are readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6cc1f35d-ff33-404e-aa5e-b01eab89863e (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11372b3d-52c0-4694-8c88-4b72d3fda9d0 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a50329b-b272-4164-bddf-0d6cea3d7a23 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54d72943-f8d1-5a78-e063-6294a90a059b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8df3eed3-c936-4772-ab08-574c54dd8bf5 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:823b1d71-a510-4d34-8015-60b55af23d78 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0681c8db-ff09-4258-a5e0-76a26b0ea0af (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c1caa9c-9ef1-459c-86c3-adb939130a9f (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5407f327-3a22-8c15-e063-6294a90a3169 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56093df3-10f6-e747-e063-6294a90a6564 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e563594e-212c-4f31-92ea-294aeab45df3 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:82f79757-69f0-4a37-93a6-55b66ae86ad7 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ce02d7d-d855-c73f-e063-6294a90abe93 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:973eff80-b2cd-42ca-8e88-e0151e691e59 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a57e549-390b-5482-e063-6394a90aeb3b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17919c82-87f2-5030-e063-6294a90ac91a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0a33933-f697-4d3b-ba99-8a995a4b6c6b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b707ecb2-644c-4323-ab0e-7bc5929cd560 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:569e8a5a-ddf7-ebbc-e063-6294a90ab7a4 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:787240e9-67b5-4af3-b16d-7cf314e3f2e3 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8361519b-be1a-4542-a782-d7cdfa153e86 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29f63525-2839-946c-e063-6294a90aebb1 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:853c762d-0772-4f02-99ca-0bc2911f09f0 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba34ddd2-9a47-48bf-8e55-f05e9085e5a8 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:247110f2-5468-4593-8d86-41f8c869e03d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:386255e2-65aa-48ce-9eb1-246f1493cc14 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:08a30230-fc95-9025-e063-6394a90ae21b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c20c89f-c8c3-43b3-837e-da413f449795 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7999b9c3-6185-4e4e-a4c3-d5d33d6c31d6 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:551a1b7f-d342-2c53-e063-6394a90a9a2a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0cd02e52-ead5-4b2a-9708-c7c4be7b7995 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c5356b1-c199-49ad-bb00-fd67c6691f74 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6dfbe8be-168c-44e9-acfa-fa838b92d3b7 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ebdf72f7-7462-4b83-81b4-c7988860c728 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf265c2e-ab2f-42e5-96cf-3998eb5a644d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e3d44fb-24b7-4552-9e95-de3bf871a88b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:86630bdd-13ad-4ab5-9e94-fcf2ea2113e1 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:89057c93-8155-4040-acec-64e877bd2b4c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Ativan (lorazepam) is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6364be4-056b-4ebe-83bc-3fc85e8f488c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bcf608a-11c1-ec7d-e063-6394a90ab710 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bf22e97-9425-484d-bac6-519c6bae6a37 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7afd9a59-3463-4eda-8cf3-ef90be05de3d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7fa1a011-5e28-4b13-bcd2-5c5fc9b663b2 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readilyabsorbedwithanabsolutebioavailability of 90%.Peakconcentrations in plasmaoccurapproximately 2 hoursfollowingadministration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac1f88c2-2cf2-47de-a612-946cd4503090 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a407d3fe-ff0f-45b0-8a1e-c7a2a11c5569 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ca13415-4b77-4131-a9d2-6db26bc49167 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32fb5628-bf80-0135-e063-6294a90aa3ab (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45e31a87-a8db-4dda-b94b-83535b62e8e2 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51119efa-c1a3-71f0-e063-6394a90a9e2a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52614947-c96c-3361-e063-6394a90ae172 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46af8e93-3169-408a-b4d8-b8498642801d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1009c870-fd98-4e3b-81c8-4184036fb8c2 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:711b60a3-028d-41d4-aa17-8f976e6df23e (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1791d5c9-9004-5c4b-e063-6294a90adf3d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00960fbd-a5da-408b-9867-62982f20906f (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:903351ae-1bb0-4ac0-8430-df24cf2eee76 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readilyabsorbedwithanabsolutebioavailability of 90%.Peakconcentrations in plasmaoccurapproximately 2 hoursfollowingadministration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b851f67-309d-4ef3-8b4b-ade8908256ea (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readilyabsorbedwithanabsolutebioavailability of 90%.Peakconcentrations in plasmaoccurapproximately 2 hoursfollowingadministration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5114810c-025f-6113-e063-6294a90af538 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f79a5a1-0c40-45cf-8994-51f5ba3a5938 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8602cef8-167e-4a8c-b10f-fc3295a3abcc (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91da80c8-3162-43f0-b53e-897070b26a54 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ddcc0b2b-4be2-6d18-e053-2a95a90af987 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:62f6eb3b-813d-4890-aca9-799b7fa890df (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0418ad09-3069-4381-9a8f-e41b234fdac6 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readilyabsorbedwithanabsolutebioavailability of 90%.Peakconcentrations in plasmaoccurapproximately 2 hoursfollowingadministration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5519bba8-9eb7-a3e0-e063-6294a90afd94 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be9f8bda-1cd9-40a6-a4da-b5961389fb5b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed37d304-04cf-43ec-a58d-d72002ff889b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Lorazepam is readily absorbed with an absolute bioavailability of 90%.
Projected row 894
- Medicine slug
- lorazepam
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 106
- Source count
- 99
- Agreement rate
- 0.89899
- Recorded readings
12 hours
- Numeric value
- 12
- Unit
- hours
- Source records
- 89
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 89 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aac672f9-0ba7-4852-b8a7-caac9e4b1e77 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:933b5ef3-ec29-1a96-e053-2995a90a2d33 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be85b116-9f09-403a-8e0d-e77e344d3a9a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b0619c5-b9e9-47e7-97b5-7e581e67cf5f (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:503834f9-fa2e-5e23-e054-00144ff88e88 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6cc1f35d-ff33-404e-aa5e-b01eab89863e (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11372b3d-52c0-4694-8c88-4b72d3fda9d0 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a50329b-b272-4164-bddf-0d6cea3d7a23 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54d72943-f8d1-5a78-e063-6294a90a059b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ab77192-8fe9-2965-e054-00144ff88e88 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8df3eed3-c936-4772-ab08-574c54dd8bf5 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c956cc1-9217-46e0-80a3-7c811163d3f1 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:823b1d71-a510-4d34-8015-60b55af23d78 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0681c8db-ff09-4258-a5e0-76a26b0ea0af (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b6e4d2c7-10c0-4d77-be7b-caa3d3b86997 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4832f02d-289c-2fe6-e054-00144ff8d46c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c1caa9c-9ef1-459c-86c3-adb939130a9f (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5407f327-3a22-8c15-e063-6294a90a3169 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56093df3-10f6-e747-e063-6294a90a6564 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e563594e-212c-4f31-92ea-294aeab45df3 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:82f79757-69f0-4a37-93a6-55b66ae86ad7 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ce02d7d-d855-c73f-e063-6294a90abe93 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:973eff80-b2cd-42ca-8e88-e0151e691e59 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fdc11b95-2233-42b4-b5f3-9390b5e9e1b2 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a57e549-390b-5482-e063-6394a90aeb3b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17919c82-87f2-5030-e063-6294a90ac91a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0a33933-f697-4d3b-ba99-8a995a4b6c6b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b707ecb2-644c-4323-ab0e-7bc5929cd560 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:569e8a5a-ddf7-ebbc-e063-6294a90ab7a4 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:787240e9-67b5-4af3-b16d-7cf314e3f2e3 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8361519b-be1a-4542-a782-d7cdfa153e86 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29f63525-2839-946c-e063-6294a90aebb1 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:853c762d-0772-4f02-99ca-0bc2911f09f0 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4fa14be-cef1-4b4b-b099-abde92f15145 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba34ddd2-9a47-48bf-8e55-f05e9085e5a8 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:247110f2-5468-4593-8d86-41f8c869e03d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73bf2b31-5c7e-4b3a-9e97-8304931510b0 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:386255e2-65aa-48ce-9eb1-246f1493cc14 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:08a30230-fc95-9025-e063-6394a90ae21b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c20c89f-c8c3-43b3-837e-da413f449795 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7999b9c3-6185-4e4e-a4c3-d5d33d6c31d6 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:551a1b7f-d342-2c53-e063-6394a90a9a2a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0cd02e52-ead5-4b2a-9708-c7c4be7b7995 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c5356b1-c199-49ad-bb00-fd67c6691f74 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6dfbe8be-168c-44e9-acfa-fa838b92d3b7 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ebdf72f7-7462-4b83-81b4-c7988860c728 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf265c2e-ab2f-42e5-96cf-3998eb5a644d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9052b38-3c9f-4c84-9a0d-98bd99b9ddfd (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e3d44fb-24b7-4552-9e95-de3bf871a88b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:86630bdd-13ad-4ab5-9e94-fcf2ea2113e1 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:89057c93-8155-4040-acec-64e877bd2b4c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6364be4-056b-4ebe-83bc-3fc85e8f488c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bcf608a-11c1-ec7d-e063-6394a90ab710 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a66b854-4dc1-3746-e054-00144ff8d46c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bf22e97-9425-484d-bac6-519c6bae6a37 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7afd9a59-3463-4eda-8cf3-ef90be05de3d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac1f88c2-2cf2-47de-a612-946cd4503090 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e075c78d-f0c6-4380-b769-bb8833d23ba5 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:08bd30b0-a1c1-4ec3-bb9c-b1d55ac59f75 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a407d3fe-ff0f-45b0-8a1e-c7a2a11c5569 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8aace309-f3ef-6aef-e053-2995a90aa197 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4fe8df0-3ce8-b8b8-e053-2995a90a28f4 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8fa33078-c379-41f5-e053-2995a90acced (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ca13415-4b77-4131-a9d2-6db26bc49167 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8aaf9bcb-7a4e-ffaa-e053-2995a90a3913 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32fb5628-bf80-0135-e063-6294a90aa3ab (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:891b2c10-942f-0e4d-e053-2995a90af028 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45e31a87-a8db-4dda-b94b-83535b62e8e2 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51119efa-c1a3-71f0-e063-6394a90a9e2a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52614947-c96c-3361-e063-6394a90ae172 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46af8e93-3169-408a-b4d8-b8498642801d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb068a0f-5c0e-4218-b4c5-a0d0b1d362bd (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1009c870-fd98-4e3b-81c8-4184036fb8c2 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:711b60a3-028d-41d4-aa17-8f976e6df23e (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b78f7af-0ad8-4fa1-a8c0-9308fe8d9b3a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1791d5c9-9004-5c4b-e063-6294a90adf3d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00960fbd-a5da-408b-9867-62982f20906f (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5114810c-025f-6113-e063-6294a90af538 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f79a5a1-0c40-45cf-8994-51f5ba3a5938 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8602cef8-167e-4a8c-b10f-fc3295a3abcc (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91da80c8-3162-43f0-b53e-897070b26a54 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e83ae439-3fa5-453f-9073-4bf8c797df47 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50379c41-2676-590c-e054-00144ff8d46c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ddcc0b2b-4be2-6d18-e053-2a95a90af987 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:62f6eb3b-813d-4890-aca9-799b7fa890df (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a66b854-4dd6-3746-e054-00144ff8d46c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5519bba8-9eb7-a3e0-e063-6294a90afd94 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be9f8bda-1cd9-40a6-a4da-b5961389fb5b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed37d304-04cf-43ec-a58d-d72002ff889b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
The mean half-life of unconjugated lorazepam in human plasma is about 12 hours and for its major metabolite, lorazepam glucuronide, about 18 hours.
14±5 hours
- Numeric value
- 14
- Unit
- hours
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4084fa74-9fd2-45ef-9d56-27bfa31d4e46 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Following parenteral administration, the terminal half-life and total clearance averaged 14±5 hours and 1.1±0.4 mL/min/kg, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7dda070d-7809-46c4-8592-eb4e4c509707 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Following parenteral administration, the terminal half-life and total clearance averaged 14 ± 5 hours and 1.1 ± 0.4 mL/min/kg, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5140798d-8571-41fb-84a4-e182aac3f64c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Following parenteral administration, the terminal half-life and total clearance averaged 14±5 hours and 1.1±0.4 mL/min/kg, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b79b38ee-c29d-4099-964f-000031f47f5a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Following parenteral administration, the terminal half-life and total clearance averaged 14±5 hours and 1.1±0.4 mL/min/kg, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20140b19-846b-425f-b191-670e17809945 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Following parenteral administration, the terminal half-life and total clearance averaged 14 ± 5 hours and 1.1 ± 0.4 mL/min/kg, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5a02c97d-637d-43f7-803c-afe4381ccc59 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Following parenteral administration, the terminal half-life and total clearance averaged 14 ± 5 hours and 1.1 ± 0.4 mL/min/kg, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9b54e42-04cf-4c62-90e1-36f7b31a4e81 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Following parenteral administration, the terminal half-life and total clearance averaged 14±5 hours and 1.1±0.4 mL/min/kg, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5fc0e987-61c9-40c4-b0d5-fcea07c8733e (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Following parenteral administration, the terminal half-life and total clearance averaged 14±5 hours and 1.1±0.4 mL/min/kg, respectively.
20.2 ± 7.2 hours
- Numeric value
- 20.2
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:227734c1-bf01-9607-73ea-5a1f38a89bd9 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Elimination Oral mean plasma clearance (CL/F) is about 72 mL/min in adults following a single 3 mg dose of LOREEV XR and the mean elimination half-life of lorazepam is approximately 20.2 ± 7.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c470fdee-8e18-4da9-b072-943d6b2518cf (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Elimination Oral mean plasma clearance (CL/F) is about 72 mL/min in adults following a single 3 mg dose of LOREEV XR and the mean elimination half-life of lorazepam is approximately 20.2 ± 7.2 hours.
Projected row 895
- Medicine slug
- lorazepam
- Compared field
- tMax
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 106
- Source count
- 100
- Agreement rate
- 0.88
- Recorded readings
2 hours
- Numeric value
- 2
- Unit
- hours
- Source records
- 88
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 88 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aac672f9-0ba7-4852-b8a7-caac9e4b1e77 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:933b5ef3-ec29-1a96-e053-2995a90a2d33 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be85b116-9f09-403a-8e0d-e77e344d3a9a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6b0619c5-b9e9-47e7-97b5-7e581e67cf5f (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:503834f9-fa2e-5e23-e054-00144ff88e88 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6cc1f35d-ff33-404e-aa5e-b01eab89863e (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11372b3d-52c0-4694-8c88-4b72d3fda9d0 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a50329b-b272-4164-bddf-0d6cea3d7a23 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54d72943-f8d1-5a78-e063-6294a90a059b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ab77192-8fe9-2965-e054-00144ff88e88 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8df3eed3-c936-4772-ab08-574c54dd8bf5 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c956cc1-9217-46e0-80a3-7c811163d3f1 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:823b1d71-a510-4d34-8015-60b55af23d78 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0681c8db-ff09-4258-a5e0-76a26b0ea0af (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b6e4d2c7-10c0-4d77-be7b-caa3d3b86997 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4832f02d-289c-2fe6-e054-00144ff8d46c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c1caa9c-9ef1-459c-86c3-adb939130a9f (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5407f327-3a22-8c15-e063-6294a90a3169 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56093df3-10f6-e747-e063-6294a90a6564 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e563594e-212c-4f31-92ea-294aeab45df3 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:82f79757-69f0-4a37-93a6-55b66ae86ad7 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ce02d7d-d855-c73f-e063-6294a90abe93 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:973eff80-b2cd-42ca-8e88-e0151e691e59 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fdc11b95-2233-42b4-b5f3-9390b5e9e1b2 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a57e549-390b-5482-e063-6394a90aeb3b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17919c82-87f2-5030-e063-6294a90ac91a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0a33933-f697-4d3b-ba99-8a995a4b6c6b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b707ecb2-644c-4323-ab0e-7bc5929cd560 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:569e8a5a-ddf7-ebbc-e063-6294a90ab7a4 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:787240e9-67b5-4af3-b16d-7cf314e3f2e3 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8361519b-be1a-4542-a782-d7cdfa153e86 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29f63525-2839-946c-e063-6294a90aebb1 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:853c762d-0772-4f02-99ca-0bc2911f09f0 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4fa14be-cef1-4b4b-b099-abde92f15145 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba34ddd2-9a47-48bf-8e55-f05e9085e5a8 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:247110f2-5468-4593-8d86-41f8c869e03d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73bf2b31-5c7e-4b3a-9e97-8304931510b0 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:386255e2-65aa-48ce-9eb1-246f1493cc14 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:08a30230-fc95-9025-e063-6394a90ae21b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c20c89f-c8c3-43b3-837e-da413f449795 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7999b9c3-6185-4e4e-a4c3-d5d33d6c31d6 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:551a1b7f-d342-2c53-e063-6394a90a9a2a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0cd02e52-ead5-4b2a-9708-c7c4be7b7995 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c5356b1-c199-49ad-bb00-fd67c6691f74 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6dfbe8be-168c-44e9-acfa-fa838b92d3b7 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ebdf72f7-7462-4b83-81b4-c7988860c728 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf265c2e-ab2f-42e5-96cf-3998eb5a644d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9052b38-3c9f-4c84-9a0d-98bd99b9ddfd (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e3d44fb-24b7-4552-9e95-de3bf871a88b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:86630bdd-13ad-4ab5-9e94-fcf2ea2113e1 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:89057c93-8155-4040-acec-64e877bd2b4c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6364be4-056b-4ebe-83bc-3fc85e8f488c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bcf608a-11c1-ec7d-e063-6394a90ab710 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a66b854-4dc1-3746-e054-00144ff8d46c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bf22e97-9425-484d-bac6-519c6bae6a37 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7afd9a59-3463-4eda-8cf3-ef90be05de3d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac1f88c2-2cf2-47de-a612-946cd4503090 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:08bd30b0-a1c1-4ec3-bb9c-b1d55ac59f75 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a407d3fe-ff0f-45b0-8a1e-c7a2a11c5569 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8aace309-f3ef-6aef-e053-2995a90aa197 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4fe8df0-3ce8-b8b8-e053-2995a90a28f4 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8fa33078-c379-41f5-e053-2995a90acced (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5ca13415-4b77-4131-a9d2-6db26bc49167 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8aaf9bcb-7a4e-ffaa-e053-2995a90a3913 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:32fb5628-bf80-0135-e063-6294a90aa3ab (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:891b2c10-942f-0e4d-e053-2995a90af028 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45e31a87-a8db-4dda-b94b-83535b62e8e2 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51119efa-c1a3-71f0-e063-6394a90a9e2a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52614947-c96c-3361-e063-6394a90ae172 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46af8e93-3169-408a-b4d8-b8498642801d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb068a0f-5c0e-4218-b4c5-a0d0b1d362bd (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1009c870-fd98-4e3b-81c8-4184036fb8c2 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:711b60a3-028d-41d4-aa17-8f976e6df23e (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b78f7af-0ad8-4fa1-a8c0-9308fe8d9b3a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1791d5c9-9004-5c4b-e063-6294a90adf3d (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00960fbd-a5da-408b-9867-62982f20906f (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5114810c-025f-6113-e063-6294a90af538 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f79a5a1-0c40-45cf-8994-51f5ba3a5938 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8602cef8-167e-4a8c-b10f-fc3295a3abcc (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91da80c8-3162-43f0-b53e-897070b26a54 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e83ae439-3fa5-453f-9073-4bf8c797df47 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50379c41-2676-590c-e054-00144ff8d46c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ddcc0b2b-4be2-6d18-e053-2a95a90af987 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:62f6eb3b-813d-4890-aca9-799b7fa890df (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4a66b854-4dd6-3746-e054-00144ff8d46c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5519bba8-9eb7-a3e0-e063-6294a90afd94 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be9f8bda-1cd9-40a6-a4da-b5961389fb5b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed37d304-04cf-43ec-a58d-d72002ff889b (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Peak concentrations in plasma occur approximately 2 hours following administration.
3 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 10
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 10 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4084fa74-9fd2-45ef-9d56-27bfa31d4e46 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Intramuscular Following intramuscular administration, lorazepam is completely and rapidly absorbed reaching peak concentrations within 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7dda070d-7809-46c4-8592-eb4e4c509707 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Intramuscular Following intramuscular administration, lorazepam is completely and rapidly absorbed reaching peak concentrations within 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5140798d-8571-41fb-84a4-e182aac3f64c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Intramuscular Following intramuscular administration, lorazepam is completely and rapidly absorbed reaching peak concentrations within 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b79b38ee-c29d-4099-964f-000031f47f5a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Intramuscular Following intramuscular administration, lorazepam is completely and rapidly absorbed reaching peak concentrations within 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2487467-a63f-48b5-b0de-3a6ce6672d50 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Intramuscular Following intramuscular administration, lorazepam is completely and rapidly absorbed reaching peak concentrations within 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20140b19-846b-425f-b191-670e17809945 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Intramuscular Following intramuscular administration, lorazepam is completely and rapidly absorbed reaching peak concentrations within 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:462a13da-259a-40e7-bd5b-f7f42ae025b7 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Intramuscular Following intramuscular administration, lorazepam is completely and rapidly absorbed reaching peak concentrations within 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5a02c97d-637d-43f7-803c-afe4381ccc59 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Intramuscular Following intramuscular administration, lorazepam is completely and rapidly absorbed reaching peak concentrations within 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9b54e42-04cf-4c62-90e1-36f7b31a4e81 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Intramuscular Following intramuscular administration, lorazepam is completely and rapidly absorbed reaching peak concentrations within 3 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5fc0e987-61c9-40c4-b0d5-fcea07c8733e (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Intramuscular Following intramuscular administration, lorazepam is completely and rapidly absorbed reaching peak concentrations within 3 hours.
14 hours
- Numeric value
- 14
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:227734c1-bf01-9607-73ea-5a1f38a89bd9 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Absorption Following a single 3 mg dose of LOREEV XR under fasted conditions, the median time to attain C max (T max ) is 14 hours, with a range of 7 to 24 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c470fdee-8e18-4da9-b072-943d6b2518cf (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Absorption Following a single 3 mg dose of LOREEV XR under fasted conditions, the median time to attain C max (T max ) is 14 hours, with a range of 7 to 24 hours.
Projected row 896
- Medicine slug
- lorazepam
- Compared field
- volumeOfDistribution
- Comparison state
- not_comparable
- Reason codes
- DENOMINATOR_MISMATCH
- Documents examined
- 106
- Source count
- 12
- Agreement rate
- 0.833333
- Recorded readings
1.3 L/kg
- Numeric value
- 1.3
- Unit
- L/kg
- Source records
- 10
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 10 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4084fa74-9fd2-45ef-9d56-27bfa31d4e46 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
DISTRIBUTION/METABOLISM/ELIMINATION At clinically relevant concentrations, lorazepam is 91±2% bound to plasma proteins; its volume of distribution is approximately 1.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7dda070d-7809-46c4-8592-eb4e4c509707 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
DISTRIBUTION/METABOLISM/ELIMINATION At clinically relevant concentrations, lorazepam is 91 ± 2% bound to plasma proteins; its volume of distribution is approximately 1.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5140798d-8571-41fb-84a4-e182aac3f64c (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
DISTRIBUTION/METABOLISM/ELIMINATION At clinically relevant concentrations, lorazepam is 91±2% bound to plasma proteins; its volume of distribution is approximately 1.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b79b38ee-c29d-4099-964f-000031f47f5a (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
DISTRIBUTION/METABOLISM/ELIMINATION At clinically relevant concentrations, lorazepam is 91±2% bound to plasma proteins; its volume of distribution is approximately 1.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2487467-a63f-48b5-b0de-3a6ce6672d50 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
DISTRIBUTION/METABOLISM/ELIMINATION At clinically relevant concentrations, lorazepam is 91±2% bound to plasma proteins; its volume of distribution is approximately 1.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20140b19-846b-425f-b191-670e17809945 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Distribution/Metabolism/Elimination At clinically relevant concentrations, lorazepam is 91 ± 2% bound to plasma proteins; its volume of distribution is approximately 1.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:462a13da-259a-40e7-bd5b-f7f42ae025b7 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
DISTRIBUTION/METABOLISM/ELIMINATION At clinically relevant concentrations, lorazepam is 91±2% bound to plasma proteins; its volume of distribution is approximately 1.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5a02c97d-637d-43f7-803c-afe4381ccc59 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Distribution/Metabolism/Elimination At clinically relevant concentrations, lorazepam is 91 ± 2% bound to plasma proteins; its volume of distribution is approximately 1.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9b54e42-04cf-4c62-90e1-36f7b31a4e81 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
DISTRIBUTION/METABOLISM/ELIMINATION At clinically relevant concentrations, lorazepam is 91±2% bound to plasma proteins; its volume of distribution is approximately 1.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5fc0e987-61c9-40c4-b0d5-fcea07c8733e (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
DISTRIBUTION/METABOLISM/ELIMINATION At clinically relevant concentrations, lorazepam is 91±2% bound to plasma proteins; its volume of distribution is approximately 1.3 L/kg.
117 L
- Numeric value
- 117
- Unit
- L
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:227734c1-bf01-9607-73ea-5a1f38a89bd9 (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Distribution Following a single 3 mg dose of LOREEV XR under fasted conditions, the mean apparent volume of distribution is approximately 117 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c470fdee-8e18-4da9-b072-943d6b2518cf (opens source in a new tab)
Lorazepam label
Version not recorded · Effective date not recorded
Distribution Following a single 3 mg dose of LOREEV XR under fasted conditions, the mean apparent volume of distribution is approximately 117 L.
Projected row 897
- Medicine slug
- lorlatinib
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
81%
- Numeric value
- 81
- Unit
- %
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b34d62d-e02a-4af3-bc0d-1571dd4ee76d (opens source in a new tab)
Lorlatinib label
Version not recorded · Effective date not recorded
The mean absolute bioavailability is 81% (90% CI 76%, 86%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:004f93d7-a1cd-4b67-9207-31cdcb5c5976 (opens source in a new tab)
Lorlatinib label
Version not recorded · Effective date not recorded
The mean absolute bioavailability is 81% (90% CI 76%, 86%).
Projected row 898
- Medicine slug
- lorlatinib
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
1.2 hours
- Numeric value
- 1.2
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b34d62d-e02a-4af3-bc0d-1571dd4ee76d (opens source in a new tab)
Lorlatinib label
Version not recorded · Effective date not recorded
Absorption The median lorlatinib T max is 1.2 hours (0.5 to 4 hours) following a single oral 100 mg dose and 2 hours (0.5 to 23 hours) following 100 mg orally once daily at steady‑state.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:004f93d7-a1cd-4b67-9207-31cdcb5c5976 (opens source in a new tab)
Lorlatinib label
Version not recorded · Effective date not recorded
Absorption The median lorlatinib T max is 1.2 hours (0.5 to 4 hours) following a single oral 100 mg dose and 2 hours (0.5 to 23 hours) following 100 mg orally once daily at steady‑state.
Projected row 899
- Medicine slug
- losartan
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 140
- Source count
- 140
- Agreement rate
- 1
- Recorded readings
33%
- Numeric value
- 33
- Unit
- %
- Source records
- 140
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 140 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be2432ba-2118-418a-addf-56db9b6c39d2 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cff0c9eb-fafd-48e7-a053-036b676bf57d (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43fa4762-cc0c-4a3b-a527-6aa7fb7c5464 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eace2965-c02b-49ec-aad8-3a69a6ae9cbf (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c80b36c2-fa22-e7a9-e053-2a95a90ae21e (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba76eb91-bea6-4e37-e053-2a95a90a065a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:372ba4ad-26ca-4675-8475-4b664fbecba9 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4b81f90-bcd0-45d0-99ce-35ca998d473a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e136356b-e4d2-4e00-a409-35825c5637c9 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c43e9dc6-2c8a-47d7-b40d-eb55dfe11a51 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eeb77c84-38d3-432d-914a-54b312b374bd (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9130921b-02f0-82d6-e053-2995a90a9c0a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b298291-4251-4af8-a436-58a3443a7978 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
Following oral administration, losartan is well absorbed (based on absorption of radiolabeled losartan) and undergoes substantial first-pass metabolism; the systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d1b03bb-2355-baac-e063-6294a90a9b40 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:351d3c5c-05c6-921a-e063-6394a90abef9 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3585fdcc-d22a-b0a6-e063-6294a90a9b0c (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:726002cf-2d95-4dac-b1f6-e7f92bb13496 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1000341-9f81-403f-a8e4-55e1eead432a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16a6a582-eb4d-41bc-9d49-fc1d4117b29a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c565e7ba-97aa-4a65-80e6-543e9af6e1c4 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5edb843a-66ed-4950-9ed0-393e6a5d7c99 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bf520a2-a50e-a6ae-0fdf-9be4e69729c0 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c15387df-87a4-4784-acb5-7dd550498f8f (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b83d896a-c7e9-4508-814c-425b88a87b16 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:679be0b9-bb60-4970-ad50-0041a6d67bf8 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20421665-0401-4f6e-9e1d-232c654efb0f (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e8075254-cdfd-44f3-a9c2-1ed913f846ea (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a11075f1-f7d0-0c3d-e053-2995a90a0c9d (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de5c0c87-e90b-fc14-e053-2a95a90af0c5 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:94eb89aa-296f-4e8f-a077-30a1be01ad52 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cafd54e8-42a8-474c-8ea8-49ec74c2b0d3 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9dfae69-9ce7-0c6b-e053-2a95a90aace8 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:23117ad8-39ad-44f2-b7d2-2dbc8edc9734 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9a92771-5c73-4f17-ac38-29fabfd4a919 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3233c707-70b6-4c29-8210-913eeb2a38ed (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f39f7f9-edac-45ca-9ee2-c2ecad0915ab (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9501dfaa-c8cf-46d6-8bec-936c4fd8fe03 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5833c02c-9957-a069-e063-6294a90ad3e4 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05818573-0b40-4731-a9d1-152c708905bf (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:92691768-b5e6-4527-98dc-d86c58f6f13e (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:435c5544-491b-476a-b950-712b2c18e334 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b3c03e8-da8e-4c25-a493-118e760a003b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c0809dc-cbdd-1a33-e053-2995a90a4825 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1123700-f4c7-2b62-e053-2a95a90a87d6 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de987691-f659-45ab-9c53-402ef7421f4b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a945396-dd71-4b16-bfab-947982407f36 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d1b1648-8b24-cf4f-e063-6294a90afdd8 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73bb1210-fa46-4c88-b07c-14ff5580ef18 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45d0b1cc-d88d-4044-9692-c143cdf7a1b8 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c9f3e8c-eafb-4be4-aca5-1d5aa3d7d738 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ae817aa-5221-4387-a457-306785140741 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6cd0b5f-2bd6-bed9-e053-2995a90a3191 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f29cc61a-afba-4ecb-8043-5f103872f1ae (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45c01cc9-c7d1-4bb6-a105-354fc936ec63 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df4f55f0-fb11-4f6f-a7ed-127b50f955fc (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35856cd6-3fc7-2c03-e063-6294a90a2f69 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:adc984d5-91d6-ef17-e053-2a95a90a7571 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5b5da65-a4d5-1bd5-e053-2a95a90a6a60 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f260f7c5-a55b-4294-ae02-2586929e24c9 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b1f6677-9473-467f-9fb6-efadbd8828e8 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aeb4ce44-ab34-4f0e-a674-de42d404d104 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f1c20aa-2028-412d-e053-2995a90a1368 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:97a50b38-f5b3-0a96-e053-2995a90a345f (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee58207e-3913-4262-87ec-930bb4ecf07b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d7a0e82-4791-4e3f-932a-2f1a2993ba36 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31366b4b-dfd6-4fda-babe-2cb3d2c14a2b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54e902e6-d443-484a-bed1-e2669656b513 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:afd2d1ba-e7af-4e4e-8b7e-a9f72612fc97 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c810cde-fa40-4772-806e-c31809e6bbfb (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ee3240f-78a1-4fd2-a779-c22693711721 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aaf943ff-d6af-8ce2-e053-2995a90a7b76 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:394398e1-119e-4943-b414-27261f5d4842 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6eec2a4c-6b5c-11a5-e053-2991aa0aa56b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa58c629-f7d9-a6e0-e053-2995a90ac188 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68ed9727-987e-4bb6-98b4-b98150bb6404 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa0cf2c2-6238-4edd-94e2-b670b98a0da4 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca012edc-923d-4ada-a261-db82b71b3c4f (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:498f26a1-5030-4f9b-9599-07d50e912d41 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9df33c8-4ea7-5d1c-e053-2a95a90aecf7 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:552a2f78-6318-310f-e063-6394a90abb15 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91305ca4-7d56-2052-e053-2995a90a5d61 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44050993-c20e-45d4-baeb-f77d91296168 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8081b9f8-0b52-46dd-93f2-6bc608b75339 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a955160f-3c2d-3366-e053-2a95a90a65ea (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9aa536e-0747-45bf-e053-2995a90ae7d6 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a397502e-abe7-49cf-97c7-d53a616947eb (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b8f5329-4fdb-4e1d-98b1-de1ca1b171c5 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:021cd76a-b093-4704-8410-5e7d01e20a54 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67ffab1a-9e80-48dd-a6c6-1b586161fe50 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a7513c4-b73b-46fe-ba86-6e58658cdbc7 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c80b3a28-ef15-5902-e053-2995a90a06d7 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abb56236-f2fe-45b5-93ac-35fd661f8992 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53e82c07-fe4c-78db-e063-6394a90a8087 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b285c10-f468-4d87-b36d-79047f686c58 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d5524d5-c76b-44af-e063-6294a90a2ef1 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8015c22c-d944-4a49-8721-70d0c1b98526 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f55aaa2-5848-47e0-bba0-6a70b2fa05dd (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35e3472a-457f-4f95-a78d-dbff2595171d (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f738295-53d6-4d4f-8864-9faf893dbdf2 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54b363c4-00bb-08db-e054-00144ff8d46c (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
Following oral administration, losartan is well absorbed (based on absorption of radiolabeled losartan) and undergoes substantial first-pass metabolism; the systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d60e755-40a6-4187-b09e-e55c735945aa (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9de3627-9aa2-65c8-e053-2995a90ab5ec (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7b61f05-871d-4ffd-ab9b-9a3e60fd34c4 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7f6b25b-ec4c-4c3a-a541-617d2d9ab393 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41069514-0491-41fe-b7fe-a52d42d33848 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b3ddaa2-a835-736a-e053-2995a90aff08 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9949448f-c3b9-44ee-94ed-c1aca8c90f39 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1dadbe02-289c-4312-9e65-40f3314dcc31 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:364fe10e-11ca-4ee6-9f67-c85dec09aca5 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
Following oral administration, losartan is well absorbed (based on absorption of radiolabeled losartan) and undergoes substantial first-pass metabolism; the systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3bcbcb6c-ee8d-44b1-9c78-92712291e891 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c0319153-3e35-4a84-aa63-935b1e0047d8 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
Following oral administration, losartan is well absorbed (based on absorption of radiolabeled losartan) and undergoes substantial first-pass metabolism; the systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c2b3412-254b-8fa9-e053-2a95a90a7dc6 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d358499d-5ebb-75b2-e053-2a95a90a4223 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85d69d02-c5ef-467e-94aa-903100218795 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c728db3-86ae-4ed9-b86a-78ff8d18876a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3d7ddcac-508d-459c-96c8-c62f9c0b5193 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d67926b0-c22b-4803-b55d-c98a81389449 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9953f51-f30a-952d-e053-6394a90abf5f (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5886220-43b7-46e1-9034-5242ba245bd1 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25651749-8950-43ff-bcbd-3bb85f57a360 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53456224-db79-e7c1-e063-6394a90a90d5 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:628d0317-b844-42a0-9c27-48e1e23a38f5 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a8817f22-8478-49b9-8354-ab27ca222c6b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25c93638-7016-47d2-a57c-e4a5245ca41b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1843ee4b-1afc-4992-993a-4b0e03e785fc (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9ced981-d791-6600-e053-2995a90ace3b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c29d999d-adc9-6c66-e053-2995a90a1fc3 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04c4ba11-a9bd-4fed-bf14-14214f33f9c2 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f68fd1a2-1cbf-47c8-b8c4-df49cf17540e (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e0a06f3-b8bd-4178-a519-ed80362e33c2 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27e783ce-3353-448a-b0a3-c954dfd2e4c7 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3585b1d3-ccb7-747e-e063-6294a90a4b77 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eea03814-3fb5-4f85-8a4d-18e73057d880 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a58c56b2-e05c-6697-e053-2a95a90ad466 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a9e1ffd-edf1-4e35-a7f5-ca351c507d7f (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe1df76d-4925-444d-8e30-9dd07f205fb7 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5f7612dc-dccf-49e2-b541-3dab9dc1f97a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f3a6984-e601-4a74-9910-49ee5e352d6b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5529733c-1e3b-e590-e063-6294a90a765c (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f7cf8a7d-90f1-46a3-abff-1eb316aa7d72 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The systemic bioavailability of losartan is approximately 33%.
Projected row 900
- Medicine slug
- losartan
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 140
- Source count
- 140
- Agreement rate
- 1
- Recorded readings
2 hours
- Numeric value
- 2
- Unit
- hours
- Source records
- 140
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 140 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be2432ba-2118-418a-addf-56db9b6c39d2 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cff0c9eb-fafd-48e7-a053-036b676bf57d (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:43fa4762-cc0c-4a3b-a527-6aa7fb7c5464 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eace2965-c02b-49ec-aad8-3a69a6ae9cbf (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c80b36c2-fa22-e7a9-e053-2a95a90ae21e (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba76eb91-bea6-4e37-e053-2a95a90a065a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:372ba4ad-26ca-4675-8475-4b664fbecba9 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4b81f90-bcd0-45d0-99ce-35ca998d473a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e136356b-e4d2-4e00-a409-35825c5637c9 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c43e9dc6-2c8a-47d7-b40d-eb55dfe11a51 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eeb77c84-38d3-432d-914a-54b312b374bd (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9130921b-02f0-82d6-e053-2995a90a9c0a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b298291-4251-4af8-a436-58a3443a7978 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d1b03bb-2355-baac-e063-6294a90a9b40 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:351d3c5c-05c6-921a-e063-6394a90abef9 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3585fdcc-d22a-b0a6-e063-6294a90a9b0c (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:726002cf-2d95-4dac-b1f6-e7f92bb13496 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1000341-9f81-403f-a8e4-55e1eead432a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16a6a582-eb4d-41bc-9d49-fc1d4117b29a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c565e7ba-97aa-4a65-80e6-543e9af6e1c4 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5edb843a-66ed-4950-9ed0-393e6a5d7c99 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1bf520a2-a50e-a6ae-0fdf-9be4e69729c0 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c15387df-87a4-4784-acb5-7dd550498f8f (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b83d896a-c7e9-4508-814c-425b88a87b16 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:679be0b9-bb60-4970-ad50-0041a6d67bf8 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:20421665-0401-4f6e-9e1d-232c654efb0f (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e8075254-cdfd-44f3-a9c2-1ed913f846ea (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a11075f1-f7d0-0c3d-e053-2995a90a0c9d (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de5c0c87-e90b-fc14-e053-2a95a90af0c5 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:94eb89aa-296f-4e8f-a077-30a1be01ad52 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cafd54e8-42a8-474c-8ea8-49ec74c2b0d3 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9dfae69-9ce7-0c6b-e053-2a95a90aace8 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:23117ad8-39ad-44f2-b7d2-2dbc8edc9734 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9a92771-5c73-4f17-ac38-29fabfd4a919 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3233c707-70b6-4c29-8210-913eeb2a38ed (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f39f7f9-edac-45ca-9ee2-c2ecad0915ab (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9501dfaa-c8cf-46d6-8bec-936c4fd8fe03 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5833c02c-9957-a069-e063-6294a90ad3e4 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05818573-0b40-4731-a9d1-152c708905bf (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:92691768-b5e6-4527-98dc-d86c58f6f13e (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:435c5544-491b-476a-b950-712b2c18e334 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b3c03e8-da8e-4c25-a493-118e760a003b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c0809dc-cbdd-1a33-e053-2995a90a4825 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1123700-f4c7-2b62-e053-2a95a90a87d6 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de987691-f659-45ab-9c53-402ef7421f4b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a945396-dd71-4b16-bfab-947982407f36 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d1b1648-8b24-cf4f-e063-6294a90afdd8 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:73bb1210-fa46-4c88-b07c-14ff5580ef18 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45d0b1cc-d88d-4044-9692-c143cdf7a1b8 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c9f3e8c-eafb-4be4-aca5-1d5aa3d7d738 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ae817aa-5221-4387-a457-306785140741 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a6cd0b5f-2bd6-bed9-e053-2995a90a3191 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f29cc61a-afba-4ecb-8043-5f103872f1ae (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:45c01cc9-c7d1-4bb6-a105-354fc936ec63 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df4f55f0-fb11-4f6f-a7ed-127b50f955fc (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35856cd6-3fc7-2c03-e063-6294a90a2f69 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:adc984d5-91d6-ef17-e053-2a95a90a7571 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5b5da65-a4d5-1bd5-e053-2a95a90a6a60 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f260f7c5-a55b-4294-ae02-2586929e24c9 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b1f6677-9473-467f-9fb6-efadbd8828e8 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aeb4ce44-ab34-4f0e-a674-de42d404d104 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f1c20aa-2028-412d-e053-2995a90a1368 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:97a50b38-f5b3-0a96-e053-2995a90a345f (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee58207e-3913-4262-87ec-930bb4ecf07b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d7a0e82-4791-4e3f-932a-2f1a2993ba36 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31366b4b-dfd6-4fda-babe-2cb3d2c14a2b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54e902e6-d443-484a-bed1-e2669656b513 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:afd2d1ba-e7af-4e4e-8b7e-a9f72612fc97 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan and the active metabolite is about 2 hours and about 6 hours, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c810cde-fa40-4772-806e-c31809e6bbfb (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ee3240f-78a1-4fd2-a779-c22693711721 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aaf943ff-d6af-8ce2-e053-2995a90a7b76 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:394398e1-119e-4943-b414-27261f5d4842 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6eec2a4c-6b5c-11a5-e053-2991aa0aa56b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa58c629-f7d9-a6e0-e053-2995a90ac188 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68ed9727-987e-4bb6-98b4-b98150bb6404 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa0cf2c2-6238-4edd-94e2-b670b98a0da4 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca012edc-923d-4ada-a261-db82b71b3c4f (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:498f26a1-5030-4f9b-9599-07d50e912d41 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9df33c8-4ea7-5d1c-e053-2a95a90aecf7 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:552a2f78-6318-310f-e063-6394a90abb15 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91305ca4-7d56-2052-e053-2995a90a5d61 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44050993-c20e-45d4-baeb-f77d91296168 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8081b9f8-0b52-46dd-93f2-6bc608b75339 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a955160f-3c2d-3366-e053-2a95a90a65ea (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9aa536e-0747-45bf-e053-2995a90ae7d6 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a397502e-abe7-49cf-97c7-d53a616947eb (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b8f5329-4fdb-4e1d-98b1-de1ca1b171c5 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:021cd76a-b093-4704-8410-5e7d01e20a54 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67ffab1a-9e80-48dd-a6c6-1b586161fe50 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a7513c4-b73b-46fe-ba86-6e58658cdbc7 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c80b3a28-ef15-5902-e053-2995a90a06d7 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:abb56236-f2fe-45b5-93ac-35fd661f8992 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53e82c07-fe4c-78db-e063-6394a90a8087 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b285c10-f468-4d87-b36d-79047f686c58 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d5524d5-c76b-44af-e063-6294a90a2ef1 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8015c22c-d944-4a49-8721-70d0c1b98526 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f55aaa2-5848-47e0-bba0-6a70b2fa05dd (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35e3472a-457f-4f95-a78d-dbff2595171d (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f738295-53d6-4d4f-8864-9faf893dbdf2 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54b363c4-00bb-08db-e054-00144ff8d46c (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d60e755-40a6-4187-b09e-e55c735945aa (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9de3627-9aa2-65c8-e053-2995a90ab5ec (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7b61f05-871d-4ffd-ab9b-9a3e60fd34c4 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7f6b25b-ec4c-4c3a-a541-617d2d9ab393 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41069514-0491-41fe-b7fe-a52d42d33848 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b3ddaa2-a835-736a-e053-2995a90aff08 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9949448f-c3b9-44ee-94ed-c1aca8c90f39 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1dadbe02-289c-4312-9e65-40f3314dcc31 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:364fe10e-11ca-4ee6-9f67-c85dec09aca5 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3bcbcb6c-ee8d-44b1-9c78-92712291e891 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c0319153-3e35-4a84-aa63-935b1e0047d8 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c2b3412-254b-8fa9-e053-2a95a90a7dc6 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d358499d-5ebb-75b2-e053-2a95a90a4223 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85d69d02-c5ef-467e-94aa-903100218795 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c728db3-86ae-4ed9-b86a-78ff8d18876a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3d7ddcac-508d-459c-96c8-c62f9c0b5193 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d67926b0-c22b-4803-b55d-c98a81389449 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9953f51-f30a-952d-e053-6394a90abf5f (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5886220-43b7-46e1-9034-5242ba245bd1 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25651749-8950-43ff-bcbd-3bb85f57a360 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53456224-db79-e7c1-e063-6394a90a90d5 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:628d0317-b844-42a0-9c27-48e1e23a38f5 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a8817f22-8478-49b9-8354-ab27ca222c6b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25c93638-7016-47d2-a57c-e4a5245ca41b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1843ee4b-1afc-4992-993a-4b0e03e785fc (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9ced981-d791-6600-e053-2995a90ace3b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c29d999d-adc9-6c66-e053-2995a90a1fc3 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04c4ba11-a9bd-4fed-bf14-14214f33f9c2 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f68fd1a2-1cbf-47c8-b8c4-df49cf17540e (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e0a06f3-b8bd-4178-a519-ed80362e33c2 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27e783ce-3353-448a-b0a3-c954dfd2e4c7 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3585b1d3-ccb7-747e-e063-6294a90a4b77 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eea03814-3fb5-4f85-8a4d-18e73057d880 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a58c56b2-e05c-6697-e053-2a95a90ad466 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a9e1ffd-edf1-4e35-a7f5-ca351c507d7f (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe1df76d-4925-444d-8e30-9dd07f205fb7 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5f7612dc-dccf-49e2-b541-3dab9dc1f97a (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f3a6984-e601-4a74-9910-49ee5e352d6b (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5529733c-1e3b-e590-e063-6294a90a765c (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f7cf8a7d-90f1-46a3-abff-1eb316aa7d72 (opens source in a new tab)
Losartan label
Version not recorded · Effective date not recorded
The terminal half-life of losartan is about 2 hours and of the metabolite is about 6 to 9 hours.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=890Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.